Schizophrenia
Clinical research in schizophrenia focuses on persistent symptom control, with attention to positive and negative symptoms and the management of inadequately controlled disease.
- Adjunctive treatment for schizophrenia
- PANSS-based symptom assessment
- Long-term safety and tolerability
The therapeutic emphasis includes ongoing evaluation of symptom burden in adults living with chronic psychotic illness.
Psychosis associated with Alzheimer’s disease
Research in psychosis associated with Alzheimer’s disease addresses neuropsychiatric symptoms such as hallucinations and delusions in the context of Alzheimer’s disease.
- Neuropsychiatric symptoms
- Hallucinations and delusions
- Alzheimer’s disease-related psychosis
Clinical interest extends to both symptom improvement and longer-term treatment tolerability in this neurodegenerative setting.
Long-term psychiatric safety
Several studies concentrate on extended treatment exposure, with a focus on safety, tolerability, and sustained use in psychiatric disorders.
- Extended treatment safety
- Tolerability over time
- Maintenance of clinical benefit
This area reflects continued monitoring of treatment experience in both schizophrenia and Alzheimer’s disease-related psychosis.
Neuropsychiatric symptom management
The sponsor’s research activity is centered on disorders involving psychosis and broader neuropsychiatric symptom domains, with particular attention to behavioral disturbances and perceptual abnormalities.
- Psychosis treatment
- Behavioral symptoms in Alzheimer’s disease
- Clinical efficacy in psychiatric illness
These studies align with therapeutic development in central nervous system disorders affecting cognition, perception, and behavior.
